How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Sell
39
NVNO Quote, Financials, Valuation and Earnings
Last price:
$4.24
Seasonality move
:
18.84%
Day range:
$4.11 - $4.32
52-week range:
$2.03 - $6.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
402.41x
P/B ratio:
1.89x
Volume:
80.6K
Avg. volume:
122.5K
1-year change:
-33.36%
Market cap:
$72.3M
Revenue:
--
EPS (TTM):
-$1.18
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NVNO
enVVeno Medical
|
-- | -$0.28 | -- | -9.68% | $12.50 |
|
IVF
INVO Fertility
|
$1.7M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies
|
$1.8M | -- | 120.4% | -57.14% | $1.45 |
|
NTRB
Nutriband
|
$665K | -$0.17 | 59.2% | -13.33% | $15.00 |
|
SINT
SINTX Technologies
|
$400K | -$0.79 | 5.82% | -78.12% | $28.00 |
|
XAIR
Beyond Air
|
$1.7M | -- | 155.97% | -- | $2.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NVNO
enVVeno Medical
|
$4.13 | $12.50 | $72.3M | -- | $0.00 | 0% | 402.41x |
|
IVF
INVO Fertility
|
$0.80 | -- | $1.7M | -- | $0.00 | 0% | 0.07x |
|
NMTC
NeuroOne Medical Technologies
|
$0.71 | $1.45 | $35.1M | -- | $0.00 | 0% | 3.65x |
|
NTRB
Nutriband
|
$8.09 | $15.00 | $90M | -- | $0.00 | 0% | 37.41x |
|
SINT
SINTX Technologies
|
$2.78 | $28.00 | $7M | -- | $0.00 | 0% | 2.67x |
|
XAIR
Beyond Air
|
$3.16 | $2.25 | $14.7M | -- | $0.00 | 0% | 2.89x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NVNO
enVVeno Medical
|
-- | 1.389 | -- | -- |
|
IVF
INVO Fertility
|
65.97% | 1.151 | 20.29% | 0.05x |
|
NMTC
NeuroOne Medical Technologies
|
-- | 0.459 | -- | 0.93x |
|
NTRB
Nutriband
|
3.43% | 1.334 | 0.24% | 3.31x |
|
SINT
SINTX Technologies
|
2.11% | 1.788 | 1.98% | 2.98x |
|
XAIR
Beyond Air
|
41.93% | 0.040 | 42.16% | 1.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NVNO
enVVeno Medical
|
-- | -$5M | -- | -- | -- | -$4M |
|
IVF
INVO Fertility
|
$592.3K | -$2.5M | -313.33% | -714.24% | -1044.01% | -$3.6M |
|
NMTC
NeuroOne Medical Technologies
|
$771.1K | -$2.7M | -281.01% | -281.01% | -163.76% | -$59.3K |
|
NTRB
Nutriband
|
$252K | -$1.4M | -100.04% | -102.63% | -207.21% | -$1.3M |
|
SINT
SINTX Technologies
|
$45K | -$2.4M | -177.02% | -180.99% | -783.16% | -$1.4M |
|
XAIR
Beyond Air
|
-$32K | -$7.2M | -146.65% | -218.07% | -649.57% | -$8.5M |
enVVeno Medical vs. Competitors
-
Which has Higher Returns NVNO or IVF?
INVO Fertility has a net margin of -- compared to enVVeno Medical's net margin of -1063.02%. enVVeno Medical's return on equity of -- beat INVO Fertility's return on equity of -714.24%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical-- -$0.22 -- IVFINVO Fertility36.18% -$12.53 $9.8M -
What do Analysts Say About NVNO or IVF?
enVVeno Medical has a consensus price target of $12.50, signalling upside risk potential of 203.03%. On the other hand INVO Fertility has an analysts' consensus of -- which suggests that it could grow by 648.22%. Given that INVO Fertility has higher upside potential than enVVeno Medical, analysts believe INVO Fertility is more attractive than enVVeno Medical.
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical1 0 0 IVFINVO Fertility0 0 0 -
Is NVNO or IVF More Risky?
enVVeno Medical has a beta of 0.932, which suggesting that the stock is 6.781% less volatile than S&P 500. In comparison INVO Fertility has a beta of 2.045, suggesting its more volatile than the S&P 500 by 104.471%.
-
Which is a Better Dividend Stock NVNO or IVF?
enVVeno Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical pays -- of its earnings as a dividend. INVO Fertility pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or IVF?
enVVeno Medical quarterly revenues are --, which are smaller than INVO Fertility quarterly revenues of $1.6M. enVVeno Medical's net income of -$4.5M is higher than INVO Fertility's net income of -$17.4M. Notably, enVVeno Medical's price-to-earnings ratio is -- while INVO Fertility's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical is 402.41x versus 0.07x for INVO Fertility. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical402.41x -- -- -$4.5M IVFINVO Fertility0.07x -- $1.6M -$17.4M
-
Which has Higher Returns NVNO or NMTC?
NeuroOne Medical Technologies has a net margin of -- compared to enVVeno Medical's net margin of -163.76%. enVVeno Medical's return on equity of -- beat NeuroOne Medical Technologies's return on equity of -281.01%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical-- -$0.22 -- NMTCNeuroOne Medical Technologies55.61% -$0.07 $1.1M -
What do Analysts Say About NVNO or NMTC?
enVVeno Medical has a consensus price target of $12.50, signalling upside risk potential of 203.03%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 105.67%. Given that enVVeno Medical has higher upside potential than NeuroOne Medical Technologies, analysts believe enVVeno Medical is more attractive than NeuroOne Medical Technologies.
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical1 0 0 NMTCNeuroOne Medical Technologies1 0 0 -
Is NVNO or NMTC More Risky?
enVVeno Medical has a beta of 0.932, which suggesting that the stock is 6.781% less volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.052%.
-
Which is a Better Dividend Stock NVNO or NMTC?
enVVeno Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or NMTC?
enVVeno Medical quarterly revenues are --, which are smaller than NeuroOne Medical Technologies quarterly revenues of $1.4M. enVVeno Medical's net income of -$4.5M is lower than NeuroOne Medical Technologies's net income of -$2.3M. Notably, enVVeno Medical's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical is 402.41x versus 3.65x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical402.41x -- -- -$4.5M NMTCNeuroOne Medical Technologies3.65x -- $1.4M -$2.3M
-
Which has Higher Returns NVNO or NTRB?
Nutriband has a net margin of -- compared to enVVeno Medical's net margin of -208.09%. enVVeno Medical's return on equity of -- beat Nutriband's return on equity of -102.63%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical-- -$0.22 -- NTRBNutriband37.75% -$0.12 $5.3M -
What do Analysts Say About NVNO or NTRB?
enVVeno Medical has a consensus price target of $12.50, signalling upside risk potential of 203.03%. On the other hand Nutriband has an analysts' consensus of $15.00 which suggests that it could grow by 85.53%. Given that enVVeno Medical has higher upside potential than Nutriband, analysts believe enVVeno Medical is more attractive than Nutriband.
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical1 0 0 NTRBNutriband1 0 0 -
Is NVNO or NTRB More Risky?
enVVeno Medical has a beta of 0.932, which suggesting that the stock is 6.781% less volatile than S&P 500. In comparison Nutriband has a beta of 1.226, suggesting its more volatile than the S&P 500 by 22.565%.
-
Which is a Better Dividend Stock NVNO or NTRB?
enVVeno Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or NTRB?
enVVeno Medical quarterly revenues are --, which are smaller than Nutriband quarterly revenues of $667.4K. enVVeno Medical's net income of -$4.5M is lower than Nutriband's net income of -$1.4M. Notably, enVVeno Medical's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical is 402.41x versus 37.41x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical402.41x -- -- -$4.5M NTRBNutriband37.41x -- $667.4K -$1.4M
-
Which has Higher Returns NVNO or SINT?
SINTX Technologies has a net margin of -- compared to enVVeno Medical's net margin of -787.63%. enVVeno Medical's return on equity of -- beat SINTX Technologies's return on equity of -180.99%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical-- -$0.22 -- SINTSINTX Technologies15.46% -$1.29 $6.2M -
What do Analysts Say About NVNO or SINT?
enVVeno Medical has a consensus price target of $12.50, signalling upside risk potential of 203.03%. On the other hand SINTX Technologies has an analysts' consensus of $28.00 which suggests that it could grow by 907.19%. Given that SINTX Technologies has higher upside potential than enVVeno Medical, analysts believe SINTX Technologies is more attractive than enVVeno Medical.
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical1 0 0 SINTSINTX Technologies1 0 0 -
Is NVNO or SINT More Risky?
enVVeno Medical has a beta of 0.932, which suggesting that the stock is 6.781% less volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.713, suggesting its less volatile than the S&P 500 by 28.749%.
-
Which is a Better Dividend Stock NVNO or SINT?
enVVeno Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or SINT?
enVVeno Medical quarterly revenues are --, which are smaller than SINTX Technologies quarterly revenues of $291K. enVVeno Medical's net income of -$4.5M is lower than SINTX Technologies's net income of -$2.3M. Notably, enVVeno Medical's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical is 402.41x versus 2.67x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical402.41x -- -- -$4.5M SINTSINTX Technologies2.67x -- $291K -$2.3M
-
Which has Higher Returns NVNO or XAIR?
Beyond Air has a net margin of -- compared to enVVeno Medical's net margin of -697.4%. enVVeno Medical's return on equity of -- beat Beyond Air's return on equity of -218.07%.
Company Gross Margin Earnings Per Share Invested Capital NVNOenVVeno Medical-- -$0.22 -- XAIRBeyond Air-2.78% -$0.09 $24.1M -
What do Analysts Say About NVNO or XAIR?
enVVeno Medical has a consensus price target of $12.50, signalling upside risk potential of 203.03%. On the other hand Beyond Air has an analysts' consensus of $2.25 which suggests that it could grow by 1324.05%. Given that Beyond Air has higher upside potential than enVVeno Medical, analysts believe Beyond Air is more attractive than enVVeno Medical.
Company Buy Ratings Hold Ratings Sell Ratings NVNOenVVeno Medical1 0 0 XAIRBeyond Air2 1 0 -
Is NVNO or XAIR More Risky?
enVVeno Medical has a beta of 0.932, which suggesting that the stock is 6.781% less volatile than S&P 500. In comparison Beyond Air has a beta of 0.221, suggesting its less volatile than the S&P 500 by 77.879%.
-
Which is a Better Dividend Stock NVNO or XAIR?
enVVeno Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. enVVeno Medical pays -- of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVNO or XAIR?
enVVeno Medical quarterly revenues are --, which are smaller than Beyond Air quarterly revenues of $1.2M. enVVeno Medical's net income of -$4.5M is higher than Beyond Air's net income of -$8M. Notably, enVVeno Medical's price-to-earnings ratio is -- while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for enVVeno Medical is 402.41x versus 2.89x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVNOenVVeno Medical402.41x -- -- -$4.5M XAIRBeyond Air2.89x -- $1.2M -$8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Oklo Stock Double?
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
Why a $5 Stock Is Suddenly a Cash Machine
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
78
SBET alert for Jul 16
SharpLink Gaming [SBET] is up 23.06% over the past day.
Buy
75
MP alert for Jul 16
MP Materials [MP] is down 1.08% over the past day.
Sell
38
NAIL alert for Jul 16
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 1.12% over the past day.
